EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P43
Within normal range
vs 5Y Ago
-1.2x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | -90.22% |
| 2024 | -6832.05% |
| 2023 | 102.88% |
| 2022 | -29.76% |
| 2021 | -247.05% |
| 2020 | 74.54% |
| 2019 | -158.82% |
| 2018 | -6.92% |
| 2017 | -25.58% |
| 2016 | -258.45% |